Skip to content

A 3242 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
A 3242

New Jersey · 222 session · house

A 3242Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Status: In committee
Latest action: 2026-02-12 — Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee
Primary sponsor: Hutchison, Dan (Democratic)

Appropriations

Track this bill View changes+670 / −1617 words · Large

Sponsors

Hutchison, Dan (Democratic) · primaryprimary
Donlon, Margie, M.D. · primaryprimary

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

Simmons, Heather (Democratic) · primaryprimary

MDMiller, Cody D. (Democratic) · cosponsor

Versions

IntroducedJan 13, 2026
Statement—
Reprint—
Fiscal Estimate—

Legislative history

Feb 12, 2026
Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee
Jan 13, 2026
Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Official sources

Version 0PDF HTML
Version 1PDF HTML
Version 2PDF HTML
Version 3PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for A 3242. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 3242, get alerts, annotate diffs, and export Word work product.